Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Net revenue		$ 491,008	$ 482,229
Operating expenses:
Practice salaries and benefits		362,235	343,155
Practice supplies and other operating expenses		30,720	28,489
General and administrative expenses		59,059	61,287
Depreciation and amortization		8,953	8,769
Transformational and restructuring related expenses		0	1,421
Total operating expenses		460,967	443,121
Income from operations		30,041	39,108
Investment and other income		634	875
Interest expense		(10,390)	(11,818)
Loss on early extinguishment of debt		0	(57,016)
Equity in earnings of unconsolidated affiliate		427	505
Total non-operating expenses		(9,329)	(67,454)
Income (loss) from continuing operations before income taxes		20,712	(28,346)
Income tax benefit		(6,506)	7,401
Income (loss)from continuing operations		14,206	(20,945)
Loss from discontinued operations, net of tax		0	(247)
Net Income (loss)		14,206	(21,192)
Net loss attributable to noncontrolling interest		0	4
Net Income (loss) attributable to Pediatrix Medical Group, Inc.		14,206	(21,188)
Unrealized holding gain (loss) on investments, net of tax of $227 and $894		604	(2,668)
Total comprehensive income (loss) attributable to Pediatrix Medical Group, Inc.		$ 14,810	$ (23,856)
Net (loss) income attributable to Pediatrix Medical Group, Inc.:
Basic		$ 0.17	$ (0.25)
Diluted		$ 0.17	$ (0.25)
Weighted average common shares:
Basic		81,894	85,405
Diluted	[1]	82,318	85,405

[1] (a) Due to a loss from continuing operations for the three months ended March 31, 2022, 0.9 million incremental shares are not included because the effect would be antidilutive.